Gap junction regulation of vascular tone: Implications of modulatory intercellular communication during gestation

Advances in Experimental Medicine and Biology

Volumn 814, Issue , 2014, Pages 117-132

  Ampey, Bryan C ^a   Morschauser, Timothy J ^a   Lampe, Paul D ^b   Magness, Ronald R ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b USA   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Connexins; Cyclic nucleotides; Endothelium; Nitric oxide; Uterine blood flow; Vasodilation

Indexed keywords

CASEIN KINASE I; CONNEXIN 37; CONNEXIN 40; CONNEXIN 43; CONNEXIN 45; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; CYCLIN DEPENDENT KINASE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PROSTACYCLIN; PROTEIN KINASE C; PROTEIN KINASE P60; SERINE; THREONINE; TYROSINE;

ALTITUDE ACCLIMATIZATION; ARTERIAL PRESSURE; BLOOD VESSEL TONE; CELL COMMUNICATION; CELL CYCLE REGULATION; CELL MEMBRANE; CELL MIGRATION; CELL STRUCTURE; CX GENE; ENDOTHELIUM CELL; ENZYME ACTIVITY; GAP JUNCTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NUTRIENT; OXYGEN TRANSPORT; PHOSPHORYLATION; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TISSUE PERFUSION; UPREGULATION; UTERINE ARTERY ENDOTHELIAL CELL; UTERINE VASCULAR RESISTANCE; UTERUS BLOOD FLOW; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE CELL; VASCULARIZATION; VASOMOTOR REFLEX; ANIMAL; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; FEMALE; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; CELL COMMUNICATION; ENDOTHELIUM, VASCULAR; FEMALE; GAP JUNCTIONS; HUMANS; PREGNANCY;

EID: 84921685096     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1031-1_11     Document Type: Review

References (146)

1. Goodenough DA, Paul DL. Gap junctions. Cold Spring Harb Perspect Biol. 2009;1:a002576.
2. Gros DB, Jongsma HJ. Connexins in mammalian heart function. Bioessays. 1996;18:719-30.
3. Solan JL, Lampe PD. Connexin phosphorylation as a regulatory event linked to gap junction channel assembly. Biochim Biophys Acta. 2005;1171: 154-63.
4. van Veen AA, van Rijen HV, Opthof T. Cardiac gap junction channels: modulation of expression and channel properties. Cardiovasc Res. 2001;51: 217-29.
5. Yamasaki H, Krutovskikh V, Mesnil M, Omori Y. Connexin genes and cell growth control. Arch Toxicol. 1996;18:105-14.
6. Morschauser TJ, Ramadoss J, Koch JM, Yi FX, Lopez GE, Bird IM, et al. Local effects of pregnancy on connexin proteins that me diate Ca 2+-Associated uterine endothelial NO synthesis. Hypertension 2013 (In Press
7. Yi FX, Boeldt DS, Gifford SM, Sullivan JA, Grummer MA, Magness RR, et al. Pregnancy enhances sustained Ca2 + bursts and endothelial nitric oxide synthase activation in ovine uterine artery endothelial cells through increased connexin 43 function. Biol Reprod. 2010;82:66-75.
8. Sandow SL, Tare M, Coleman HA, Hill CE, Parkington HC. Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ Res. 2002;90:1108-13.
9. Coleman HA, Tare M, Parkington HC. Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease. Clin Exp Pharmacol Physiol. 2004;31:6 41-9.
10. Xia J, Duling BR. Electromechanical coupling and the conducted vasomotor response. Am J Physiol. 1995;269:H2022-30.
11. Welsh DG, Segal SS. Endothelial and smooth muscle cell conduction in arterioles controlling blood flow. Am J Physiol. 1998;274:H178-86.
12. Alexander DB, Goldberg GS. Transfer of biologically important molecules between cells through gap junction channels. Curr Med Chem. 2003;10:2045-58.
13. Janowiak MA, Magness RR, Habermehl DA, Bird IM. Pregnancy increases ovine uterine artery endothelial cyclooxygenase-1 expression. Endocrinology. 1998;139:765-71.
14. Cunningham FG, MacDonald PC, Gant NF. Maternal adaptations to pregnancy. In: Cunningham FG, MacDonald PC, Gant NF, editors. Williams obstetrics. 18th ed. Norwalk, CT: Appleton & Lange; 1989.
15. Magness RR. Maternal cardiovascular and other physiologic responses to the endocrinology of pregnancy. In: Bazer FW, editor. Endocrinology of pregnancy. Totowa, NJ: Humana; 1998. p. 507-39.
16. Magness RR, Zheng J. Maternal cardiovascular alterations during pregnancy. In: Gluckman PD, Heymann MA, editors. Pediatrics and perinatology: the scientific basis. 2nd ed. London: Arnold Publishing; 1996.
17. Bird IM, Sullivan JA, Di T, Cale JM, Zhang L, Zheng J, et al. Pregnancy-dependent changes in cell signaling underlie changes in differential control of vasodilator production in uterine artery endothelial cells. Endocrinolog y. 2000;141:1107-17.
18. Magness RR, Shaw CE, Phernetton TM, Zheng J, Bird IM. Endothelial vasodilator production by uterine and systemic arteries. II. Pregnancy effects on NO synthase expre ssion. Am J Physiol. 1997;272: H1730-40.
19. Civitelli R, Ziambaras K, Warlow PM, Lecanda F, Nelson T, Harley J, et al. Regulation of connexin43 expression and function by prostaglandin E2 ( PGE2) and parathyroid hormone (PTH) in osteoblastic cells. J Cell Biochem. 1998;68:8-21.
20. Xia X, Batra N, Shi Q, Bonewald LF, Sprague E, Jiang JX. Prostaglandin promotion of osteocyte gap junction function through transcriptional regulation of connexin 43 by glycogen synthase kinase 3/betacatenin signaling. Mol Cell Biol. 2010;30:206-19.
21. Broughton PF. Risk factors for preeclampsia. N Engl J Med. 2001;344:925-6.
22. Lang U, Baker RS, Braems G, Zygmunt M, Kunzel W, Clark KE. Uterine blood flow: a determinant of fetal growth. Eur J Obstet Gynecol Reprod Biol. 2003;110 Suppl 1:S55-61.
23. Leeman L,Fontaine P. Hypertensive disorders of pregnancy Am Fam Physician. 2008 78,93-100.
24. Zamudio S, Palmer SK, Dahms TE, Berman JC, Young DA, Moore LG. Alterations in uteroplacental blood flow precede hypertension in preeclampsia at high altitude. J Appl Physiol. 1995;79:15-22.
25. de Wit C, Roos F, Bolz SS, Pohl U. Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion. Physiol Genomics. 2003;13:169-77.
26. Rummery NM, Hill CE. Vascular gap junctions and implications for hypertension. Clin Exp Pharmacol Physiol. 2004;31:659-67.
27. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev. 2003;83:1359-400.
28. Sö hl G, Willecke K. An update on connexin genes and their nomenclature in mouse and man. Cell Commun Adhes. 2003;10:173-80.
29. Cottrell GT, Wu Y, Burt JM. Cx40 and Cx43 expression ratio influences heteromeric/heterotypic gap junction channel properties. Am J Physiol Cell Physiol. 2002;282:C1469-82.
30. Brisset AC, Isakson BE, Kwak BR. Connexins in vascular physiology and pathology. Antioxid Redox Signal. 2009;11:267-82.
31. Johnstone S, Isakson B, Locke D. Biological and biophysical properties of vascular connexin channels. Int Rev Cell Mol Biol. 2009;278:69-118.
32. Li X, Simard JM. Connexin45 gap junction channels in rat cerebral vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2001;281:H1890-8.
33. Tsai CH, Yeh H I, Tian TY, Lee YN, Lu CS, Ko YS. Down-regulating effect of nicotine on connexin43 gap junctions in human umbilical vein endothelial cells is attenuated by statins. Eur J Cell Biol. 2004;82:589-95.
34. van Kempen MJ, Jongsma HJ. Distribution of connexin37, connexin40 and connexin43 in the aorta and coronary artery of several mammals. Histochem Cell Biol. 1999;112:479-86.
35. van Rijen HV, van Kempen MJ, Postma S, Jongsma HJ. Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells. Cytokine. 1998;10:258-64.
36. Haddock RE, Grayson TH, Brackenbury TD, Meaney KR, Neylon CB, Sandow SL, et al. Endothelial coordination of cerebral vasomotion via myoendothelial gap junctions containing connexins 37 and Am J Physiol Heart Circ Physiol. 2006;291:H2047-56.
37. Haefliger JA, Nicod P, Meda P. Contribution of connexins to the function of the vascular wall. Cardiovasc Res. 2004;62:345-56.
38. Hill CE, Rummery N, Hickey H, Sandow SL. Heterogeneity in the distribution of vascular gap junctions and connexins: implications for function. Clin Exp Pharmacol Physiol. 2002;29:620-5.
39. Laird DW. Life cycle of connexins in health and disease. Biochem J. 2006;394:527-43.
40. Lye SJ, Nicholson BJ, Mascarenhas M, MacKenzie L, Petrocelli T. Increased expression of connexin-43 in the rat myometrium during labor is associated with an increase in the plasma estrogen:progesterone ratio. Endocrinology. 1993;132:2380-6.
41. Oyamada M, Takebe K, Oyamada Y. Regulation of connexin expression by transcription factors and epigenetic mechanisms. Biochim Biophys Acta. 1828;2013:118-33.
42. Lampe PD, Lau AF. Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys. 2000;384:205-15.
43. Willecke K,Eiberger J,Degen J,Eckardt D,Romualdi A,Güldenagel M,et al. Structural and functional diversity of connexin genes in the mouse and human genome Biol Chem. 2002, 383, 725-37.
44. Laird DW, Puranam KL, Revel JP. Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes. Biochem J. 1991;273:67-72.
45. Crow DS, Beyer EC, Paul DL, Kobe SS, Lau AF. Phosphorylation of connexin43 gap junction protein in uninfected and Rous sarcoma virus-transformed mammalian fibroblasts. Mol Cell Biol. 1990;10: 1754-63.
46. Musil LS, Beyer EC, Goodenough DA. Expression of the gap junction protein connexin43 in embr yonic chick lens: molecular cloning, ultrastructural localization, and post-translational phosphorylation. J Membr Biol. 1990;116:163-75.
47. Musil LS, Cunningham BA, Edelman GM, Goodenough DA. D ifferential phosphorylation of gap junction protein connexin43 in junctional communication-competent and deficient cell lines. J Cell Biol. 1990;111:2077-88.
48. Musil LS, Goodenough DA. Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J Cell Biol. 1991;115:1357-74.
49. Laird DL, Castillo M, Kasprzak L. Gap junction turnover, intracellular trafficking, and phosphorylation of connexin43 in Brefeldin A-treated rat mammary tumor cells. J Cell Biol. 1995;131:1193-203.
50. Lampe PD, Kurata WE, Warn-Cramer B, Lau AF. Formation of a distinct connexin43 phosphoisoform in mitotic cells is dependent upon p34cdc2 kinase. J Cell Sci. 1998;111:833-41.
51. Warn-Cramer BJ, Lampe PD, Kurata WE, Kanemitsu MY, Loo LWM, Eckhart W, et al. Characterization of the MAP kinase phosphorylation sites on the connexin43 gap junction protein. J Biol Chem. 1996; 271: 3779-86.
52. Lampe PD, Lau AF. The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol. 2004;36:1171-86.
53. Atkinson MM, Lampe PD, Lin HH, Kollander R, Li XR, Kiang DT. Cyclic AMP modifies the cellular distribution of connexin43 and induces a persistent increase in the junctional permeability of mouse mammary tumor cells. J Cell Sci. 1995;108:30 79-90.
54. Paulson AF, Lampe PD, Meyer RA, TenBroek E, Atkinson MM, Walseth TF, et al. Cyclic AMP and LDL trigger a rapid enhancement in gap junction assembly through a stimulation of connexin trafficking . J Cell Sci. 2000;113:3037-49.
55. Yogo K, Ogawa T, Akiyama M, Ishida-Kitagawa N, Sasada H, Sato E, et al. PKA implicated in the phosphorylation of Cx43 induced by stimulation with F SH in rat granulosa cells. J Reprod Dev. 2006; 52:321-8.
56. Bao X, Altenberg GA, Reuss L. Mechanism of regulation of the gap junction protein connexin 43 by protein kinase C-mediated phosphorylation . Am J Physiol Cell Physiol. 2004;286:C647-54.
57. Duncan JC, Fletcher WH. alpha 1 Connexin (connexin43) gap junctions and activities of cAMPdependent protein kinase and protein kinase C in developing mouse heart. Dev Dyn. 2002;223: 96-107.
58. Cooper CD, Lampe PD. Casein kinase 1 regulates connexin43 gap junction assembly. J Biol Chem. 2002;277:44962-8.
59. Cameron SJ, Malik S, Akaike M, Lerner-Marmarosh N, Yan C, Lee JD, et al. Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-Activated protein kinase1/ERK5 but not ERK1/2 kinase activation. J Biol Chem. 2003;278:18682-8.
60. Petrich BG, Gong X, Lerner DL, Wang X, Brown JH, Saffitz JE, et al. c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes. C irc Res. 2002;91:640-7.
61. Cottrell GT, Lin R, Warn-Cramer BJ, Lau AF, Burt JM. Mechanism of v-Src-And mitogen-Activated protein kinase-induced reduction of gap junction communication. Am J Physiol Cell Physiol. 2003; 284:C511-20.
62. Berthoud VM, Westphale EM, Grigoryeva A, Beyer EC. PKC isoenzymes in the chicken lens and TPAinduced effects on intercellular communication. Invest Ophthalmo l Vis Sci. 2000;41:850-8.
63. Crow DS, Kurata WE, Lau AF. Phosphorylation of connexin43 in cells containing mutant src oncogenes. Oncogene. 1992;7:999-1003.
64. Filson AJ, Azarnia R, Beyer EC, Loewenstein WR, Brugge JS. Tyrosine phosphorylation of a gap junction protein correlates with inhibition of cell-to-cell communication. Cell Growth Differ. 1990; 1:661-8.
65. Loo LW, Berestecky JM, Kanemitsu MY, Lau AF. Pp60src-mediated phosphorylation of connexin 43, a gap junction protein. J Biol Chem. 1995; 270:12751-61.
66. Reynhout JK, Lampe PD, Johnson RG. An activator of protein kinase C inhibits gap junction communication between cultured bovine lens cells. Exp Cell Res. 1992;198:337-42.
67. Solan JL, Lampe PD. Connexin43 phosphorylation: structural changes and biological effects. Biochem J. 2009;419:261-72.
68. Sosinsky GE, Solan JL, Gaietta GM, Ngan L, Lee GJ, Mackey MR, et al. The C-terminus of conn exin43 adopts different conformations in the Golgi and gap junction as detected with structure-specific antibodies. Biochem J. 2007;408:375-85.
69. TenBroek EM, Lampe PD, Solan JL, Reynhout JK, Johnson RG. Ser364 of connexin43 and the upregulation of gap junction assembly by cAMP. J Cell Biol. 2001;155:1307-18.
70. Yogo K, Ogawa T, Akiyama M, Ishida N, Takeya T. Identification and functional analysis of novel phosphorylation sites in Cx43 in rat primary granulosa cells. FEBS Lett. 2002;531:132-6.
71. Cherian PP, Cheng B, Gu S, Sprague E, Bonewald LF, Jiang JX. Effects of mechanical strain on the function of gap junctions in osteocytes are mediated through the prostaglandin E2 receptor. J Biol Chem. 2003;278:43146-56.
72. Burghardt RC, Barhoumi R, Sewall TC, Bowen JA. Cyclic AMP induces rapid increases in gap junction permeability and changes in the cellular distribution of connexin43. J Membr Biol. 1995;148:243-53.
73. Straub AC, Johnstone SR, Heberlei n KR, Rizzo MJ, Best AK, Boitano S, et al. Site-specific connexin phosphorylation is associated with reduced heterocellular communication between smooth muscle and endothelium. J Vasc Res. 2010;47:277-86.
74. Kwak BR, Sá ez JC, Wilders R, Chanson M, Fishman GI, Hertzberg EL, et al. Effects of cGMP-dependent phosphorylation on rat and human connexin43 gap junction channels. Pflugers Arch. 1995;430:770-8.
75. Burt JM, Spray DC. Inotropic agents modulate gap junctional conductance between cardiac myocytes. Am J Physiol. 1988;254:H1206-10.
76. Matsumura K, Mayama T, Lin H , Sakamoto Y, Ogawa K, Imanaga I. Effects of cyclic AMP on the function of the cardiac gap junction during hypoxia. Exp Clin Cardiol. 2006;11:286-93.
77. De Mello WC. Further studies on the influence of cAMP-dependent protein kinase on junctional conductance in isolated heart cell pairs. J Mol Cell Cardiol. 1991;23:371-9.
78. Shah MM, Martinez AM, Fletcher WH. The connexin43 gap junction protein is phosphorylated by protein kinase A and protein kinase C: in vivo and in vitro studies. Mol Cell Biochem. 2002;238: 57-68.
79. TenBroek E, Lampe PD, Taffet SM, Reynhout J, Martyn KD, Kurata WE, et al. Enhanced gap junction assembly following the elevation of cAMP requires full length Cx43. In: Werner R, editor. Gap junctions. Amsterdam: IOS Press; 1998.
80. Somekawa S, Fukuhara S, Nakaoka Y, Fujita H, Saito Y, Mochizuki N. Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ Res. 2005;97:655-62.
81. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature. 1998;396:474-7.
82. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, et al. A family of cAMPbinding proteins that directly activate Rap1. Science. 1998;282:2275-9.
83. Dudenhausen JW, Dudenhausen R. Adenosine-3', 5'-monophosphate in amniotic fluid of normal and high-risk pregnancy (author's transl). Z Geburtsh Perinatol. 1976;180:46-50.
84. Goser R, Jaschonek K, Kindler D, Keller E, Schindler AE. Plasma cAMP in normal and abnormal human pregnancy. Gynecol Obstet Invest. 1980; 11:274-85.
85. Kopp L, Paradiz G, Tucci JR. Urinary excretion of cyclic 3',5'-Adenosine monophosph ate and cyclic 3',5'-guanosine monophosphate during and after pregnancy. J Clin Endocrinol Metab. 1977;44:590-4.
86. Ling WY,Marsh JM,LeMaire WJ. Adenosine-3',5'-monophosphate in the plasma from human pregnancy J Clin Endocrinol Metab. 1977 44,514-9.
87. Magness RR. Endothelium-derived vasoactive substances and uterine blood vessels. Semin Perinatol. 1991;15:68-78.
88. Magness RR, Rosenfeld CR, Hassan A, Shaul PW. Endothelial vasodilator production by uterine and systemic arteries. I. Effects of ANG II on PGI2 and NO in pregnancy. Am J Physiol. 1996;270:H1914-23.
89. Weathersbee PS, Hebertson RM, Lodge JR. Interrelationship of urinary levels of cyclic 3',5'-Adenosine monophosphate and cyclic 3',5'-guanosine monophosphate during pregnancy. J Reprod Med. 1979;23:279-8 3.
90. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J. 1993;7:566-71.
91. Conrad KP, Kerchner LJ, Mosher MD. Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am J Physiol. 1999;277:F48-57.
92. Itoh H, Bird IM, Nakao K, Magness RR. Pregnancy increases soluble and particulate guanylate cyclases and decreases the clearance receptor of natriuretic peptides in ovine uterine, but not systemic, arteries. Endocr inology. 1998;139:3329-41.
93. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol Regul Integr Comp Physiol. 1997;272:R441-63.
94. Rosenfeld CR , Cox BE, Roy T, Magness RR. Nitric oxide contributes to estrogen-induced vasodilation of the ovine uterine circulation. J Clin Invest. 1996;98:2158-66.
95. Yuen BH, Wittmann B, Staley K. Cyclic adenosine 3',5'-monophosphate (cAMP) in pregnancy body fluids during normal and abnormal pregnancy. Am J Obstet Gynecol. 1976;125:597-602.
96. Yuen BH, Wittmann BK, Staley K. Cyclic 3', 5'-Adenosine monophosphate in umbilical cord and maternal plasma before and after the onset of parturition. Am J Obstet Gynecol. 1977;128:219-21.
97. Habermehl DA, Janowiak MA, Vagnoni KE, Bird IM, Magness RR. Endothelial vasodilator production by uterine and systemic arteries. IV. Cyclooxygenase isoform expression during the ovarian cycle and pregnancy in sheep. Biol Reprod. 2000;62:781-8.
98. Rupnow HL, Phernetton TM, Shaw CE, Modrick ML, Bird IM, Magness RR. Endothelial vasodilator production by uterine and systemic arteries. VII. Estrogen and progesterone effects on eNOS. Am J Physiol Heart Circ Physiol. 2001;280: H1699-705.
99. Vagnoni KE, Shaw CE, Phernetton TM, Meglin BM, Bird IM, Magness RR. Endothelial vasodilator production by uterine and systemic arteries. III. Ovarian and estrogen effects on NO s ynthase. Am J Physiol Heart Circ Physiol. 1998;275:H1845-56.
100. Di T, Sullivan JA, Rupnow HL, Magness RR, Bird IM. Pregnancy induces expression of cPLA2 in ovine uterine artery but not systemic artery endothelium. J Soc Gynecol Investig. 1999;6:301-6.
101. Jobe SO, Ramadoss J, Wargin AJ, Magness RR. Estradiol-17β and its cytochrome P450-And catechol-O-methyltransferase-derived metabolite s selectively stimulate production of prostacyclin in uterine artery endothelial cells: role of estrogen receptor-β versus estrogen receptor-β. Hypertension. 2013;61:509-18.
102. Magness RR, Mitche ll MD, Rosenfeld CR. Uteroplacental production of eicosanoids in ovine pregnancy. Prostaglandins. 1990;39:75-88.
103. Magness RR, Rosenfeld CR, Faucher DJ, Mitchell MD. Uterine prostagla ndin production in ovine pregnancy: effects of angiotensin II and indomethacin. Am J Physiol. 1992;263:H188-97.
104. Magness RR, Shideman CR, Habermehl DA, Sullivan JA, Bird IM. Endothelial vasodila tor production by uterine and systemic arteries. V. Effects of ovariectomy, the ovarian cycle, and pregnancy on prostacyclin synthase expression. Prostaglandins Other Lipid Mediat. 2000;60:103-18.
105. Naden RP, Coultrup S, Arant BS, Rosenfeld CR. Metabolic clearance of angiotensin II in pregnant and nonpregnant sheep. Am J Physiol. 1985; 249:E49-55.
106. Naden RP, Rosenfeld C R. Effect of angiotensin II on uterine and systemic vasculature in pregnant sheep. J Clin Invest. 1981;68:468-74.
107. McLaughlin M.K., Roberts JM. Hemodynamic changes Chapter In Lindheimer M.D., Roberts J.M., Cunningham F.G., editors. Chesley's hypertensive disorders in pregnancy. 2nd ed. Stamford CT Appleton & Lange 1999. p. 69-102.
108. Talledo OE, Chesley LC, Zuspan FP. Renin-Angiotensin system in normal and toxemic pregnancies III. Differential sensitivity to angiotensin II and norepinephrine in toxemia of pregnancy. Am J Obstet Gynecol. 1968;100:218-21.
109. Hettiaratchi ES , Pickford M. The effect of oestrogen and progesterone on the pressor action of angiotensin in the rat. J Physiol. 1968;196:447-51.
110. Goodman RP, Killam AP, Brash AR, Branch RA. Prost acyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension. Am J Obstet Gynecol. 1982;142:817-22.
111. Lewis PJ, Shepherd GL, Ritter J, Chan SMT, Bolton PJ, Jogee M, et al. Prostacyclin and preeclampsia. Lancet. 1981;317:559.
112. Walsh SW. Eicosanoids in preeclampsia. Prostaglandins Leukot Essent Fatty Acids. 2004;70: 223-32.
113. Yamaguchi M, Mori N. 6-Keto prostaglandin F1 alpha, thromboxane B2, and 13,14-dihydro-15-keto prostaglandin F concentrations of normotensive and preeclamptic patients during pregnancy, deliv ery, and the postpartum period. Am J Obstet Gynecol. 1985;151:121-7.
114. Gant NF, Whalley PJ, Everett RB, Worley RJ, MacDonald PC. Control of vascular reactivity in pregnancy. Am J Kidney Dis. 1987;9:303-7.
115. Gant NF, Worley RJ, Everett RB, MacDonald PC. Control of vascular responsiveness during human pregnancy. Kidney Int. 1980;18:253-8.
116. Magness RR, Gant NF. Control of vascular reactivity in pregnancy: the basis for therapeutic approaches to prevent pregnancy-induced hypertension. Semin Perinatol. 1994;18:45-69.
117. Magness RR, Phernetton TM, Gibson TC, Chen DB. Uterine blood flow responses to ICI 182 780 in ovariectomized oestradiol-17beta-treated, intact follicular and pregnant sheep. J Physiol. 2005; 565:71-83.
118. Magness RR, Sullivan JA, Li Y, Phernetton TM, Bird IM. Endothelial vasodilator production by uterine and systemic arteries. VI. Ovarian and pregnancy effects on eNOS and NO(x). Am J Physiol Heart Circ Phy siol. 2001;280:H1692-8.
119. Byers MJ, Zangl A, Phernetton TM, Lopez G, Chen DB, Magness RR. Endothelial vasodilator production by ovine uterine and systemic arteries: ovarian steroid and pregnancy control of ERá and ERǎlevels. J Physiol. 2005;565:85-99.
120. Pastore MB, Jobe SO, Ramadoss J, Magness RR. ER-Á and ER-Ǎin the uterine vascular endothelium during pregnancy: functional implica tions for regulating uterine blood flow. Semin Reprod Med. 2012;30:46-61.
121. Ramadoss J, Liao WX, Morschauser TJ, Lopez GE, Patankar MS, Chen DB, et al. Endothelial caveolar hub r egulation of adenosine triphosphate-induced endothelial nitric oxide synthase subcellular partitioning and domain-specific phosphorylation. Hypertension. 2012;59:1052-9.
122. Ramadoss J, Pastore MB, Magness RR. Endothelial caveolar subcellular domain regulation of endothelial nitric oxide synthase. Clin Exper Pharm Physiol. 2013;40:753-64.
123. Weine r C, Liu KZ, Thompson L, Herrig J, Chestnut D. Effect of pregnancy on endothelium and smooth muscle: their role in reduced adrenergic sensitivity. Am J Physiol. 1991;261:H1275-83.
124. Nelson SH, Steinsland OS, Johnson RL, Suresh MS, Gifford A, Ehardt JS. Pregnancy-induced alterations of neurogenic constriction and dilation of human uterine artery. Am J Physiol. 1995;268:H1694-701.
125. Sp rague B, Chesler NC, Magness RR. Shear stress regulation of nitric oxide production in uterine and placental artery endothelial cells: experimental studies and hemodynamic models of shear stresses on endothelial cells. Int J Dev Biol. 2010;54:331-9.
126. Kublickiene KR, Lindblom B, Kruger K, Nisell H. Preeclampsia: evidence for impaired shear stressmediated nitric oxide release in uterine circulation. Am J Obstet Gynecol. 20 00;183:160-6.
127. Li Y, Zheng J, Bird IM, Magness RR. Effects of pulsatile shear stress on nitric oxide production and endothelial cell nitric oxide synthase expression by ovine fetoplacental artery endo thelial cells. Biol Reprod. 2003;69:1053-9.
128. Li Y, Zheng J, Bird IM, Magness RR. Mechanisms of shear stress-induced endothelial nitric-oxide synthase phosphorylation and expression in ovine f etoplacental artery endothelial cells. Biol Reprod. 2004;70:785-96.
129. Francis SH, Busch JL, Corbin JD, Sibley D. cGMPdependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev. 2010;62:525-63.
130. Pilz RB, Casteel DE. Regulation of gene expression by cyclic GMP. Circ Res. 2003;93:1034-46.
131. Warner TD, M itchell JA, Sheng H, Murad F. Effects of cyclic GMP on smooth muscle relaxation. Adv Pharmacol. 1994;26:171-94.
132. Yao J, Hiramatsu N, Zhu Y, Morioka T, Takeda M, Oite T, et al. Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells. J Am Soc Neph rol. 2005;16:58-67.
133. Payne JA, Alexander BT, Khalil RA. Decreased endothelium-dependent NO-cGMP vascular relaxation and hypertension in growth-restricted rats on a highsalt diet. Hypertension. 2005;43:420-7.
134. Bird IM, Zhang L, Magness RR. Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function. Am J Physiol Regul Integr Comp Physiol. 2003; 284:R245-58.
135. Davidge ST, Stranko CP, Roberts JM. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol. 1996;174:1008-13.
136. Schiessl B, Strasburger C, Bidlingmaier M, Mylonas I, Jeschke U, Kainer F, et al. Plasma-And urine concentrations of nitrite/nitrate and cyclic guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. Arch Gynecol Obstet. 2006;274:150-4.
137. Meyer-Gesch KM, Sun MY, Koch JM, Ramadoss J, Blohowiak SE, Magness RR, et al. Ovine fetal renal development impacted by multipl e fetuses and uterine space restriction. J Dev Orig Health Dis. 2013;4:411-20.
138. Sun MY, Habeck JM, Meyer KM, Koch JM, Ramadoss J, Blohowiak SE, et al. Ovine uterine space restric tion alters placental transferrin receptor and fetal iron status during late pregnancy. Pediatr Res. 2013;73:277-85.
139. Meyer KM, Koch JM, Ramadoss J, Kling PJ, Magness RR. Ovine surgical model of uterine space restriction: interactive effects of uterine anomalies and multifetal gestations on fetal and placental growth. Biol Reprod. 2010;83: 799-806.
140. Gibson TC, Phernetton TM, Wiltban k MC, Magness RR. Development and use of an ovarian synchronization model to study the effects of endogenous estrogen and nitric oxide on uterine blood flow during ovarian cycles in sheep. Biol Reprod. 2004;70:1886-94.
141. Jobe SO, Tyler CT, Magness RR. Aberrant synthesis, metabolism, and plasma accumulation of circulating estrogens and estrogen metabolites in preeclampsia: implications for vascular dysfunction. Hypertension. 2013;61:480-7.
142. Doring B, Shynlova O, Tsui P, Eckardt D, Janssen-Bienhold U, Hofmann F, et al. Ablation of connexin43 in uterine smooth muscle cells of the mouse causes delayed parturitio n. J Cell Sci. 2006;119: 1715-22.
143. Yi FX, Boeldt DS, Magness RR, Bird IM. [ca2+]i signaling vs. eNOS expression as determinants of NO output in uterine artery endothelium: relative roles in p regnancy adaptation and reversal by VEGF165. Am J Physiol Heart Circ Physiol. 2011;300:H1182-93.
144. Osol G, Mandala M. Maternal uterine vascular remodeling during pregnancy. Physiology. 2009;24: 58-71.
145. Magness RR, Ford SP. Steroid concentrations in uterine lymph and uterine arterial plasma of gilts during the estrous cycle and early pregnancy. Biol Reprod. 1982;27:871-7.
146. Magness RR, Ford SP. Estrone, estradiol-17 beta and progesterone concentrations in uterine lymph and systemic blood throughout the porcine estrous cycle. J Anim Sci. 1983;57:449-55.